Evidence map›Paper›PMID 35980386›Full record

ArticleThe Journal of experimental medicine2022

TGF-β regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection.

Yinghong Hu, William H Hudson, Haydn T Kissick, Christopher B Medina, Antonio P Baptista, Chaoyu Ma, Wei Liao, Ronald N Germain, Shannon J Turley, Nu Zhang and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Regulators of CD8Nature reviews. Immunology · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. TGF-βRII/IL-15 immunotherapeutic complex targets exhausted CD8Journal for immunotherapy of cancer · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The diversity of CD8Nature reviews. Immunology · 2025
    Review
  18. Article
  19. CCR2Cellular & molecular immunology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Yinghong HuEmory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0001-9714-8957
William H HudsonEmory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0002-2513-1213
Haydn T KissickEmory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0001-7624-5598
Christopher B MedinaEmory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0001-7441-9232
Antonio P BaptistaLaboratory of Immunoregulation and Mucosal Immunology, VIB-UGhent Center for Inflammation Research, Ghent University, Ghent, Belgium.ORCID 0000-0001-8182-8982
Chaoyu MaDepartment of Microbiology, Immunology and Molecular Genetics, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX.ORCID 0000-0001-5770-5085
Wei LiaoDepartment of Microbiology, Immunology and Molecular Genetics, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX.ORCID 0000-0002-8828-011X
Ronald N GermainLymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.ORCID 0000-0003-1495-9143
Shannon J TurleyGenentech Inc., South San Francisco, CA.ORCID 0000-0002-0307-908X
Nu ZhangDepartment of Microbiology, Immunology and Molecular Genetics, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX.ORCID 0000-0001-9695-210X
Rafi AhmedEmory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0002-9591-2621
Emory University · USNational Institutes of Health · USThe University of Texas Health Science Center at San Antonio · USCentral South University · CN

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Transgenic/KnockoutP01AI056299 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SHARPE, ARLENE H. · 2003 to 2023
$42.5M
T CELL MEMORY TO VIRUSESR01AI030048 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AHMED, RAFI · 1990 to 2022
$5.2M
Illumina NovaSeq 6000 High Throughput DNA Sequencer for Emory UniversityS10OD026799 · OD · EMORY UNIVERSITY · PI BOSINGER, STEVEN EDWARD · 2019 to 2019
$985k
Control of CD8+ T cell exhaustion by novel checkpoint moleculesR00AI153736 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI HUDSON, WILLIAM HARRIS · 2022 to 2023
$498k
NIAID NIH HHS P01 AI056299NIAID NIH HHS R00 AI153736NIAID NIH HHS R01 AI030048NIH HHS P51 OD011132NIH HHS S10 OD026799
6 · The paper itself

Abstract

Recent studies have defined a novel population of PD-1+ TCF-1+ stem-like CD8 T cells in chronic infections and cancer. These quiescent cells reside in lymphoid tissues, are critical for maintaining the CD8 T cell response under conditions of persistent antigen, and provide the proliferative burst after PD-1 blockade. Here we examined the role of TGF-β in regulating the differentiation of virus-specific CD8 T cells during chronic LCMV infection of mice. We found that TGF-β signaling was not essential for the generation of the stem-like CD8 T cells but was critical for maintaining the stem-like state and quiescence of these cells. TGF-β regulated the unique transcriptional program of the stem-like subset, including upregulation of inhibitory receptors specifically expressed on these cells. TGF-β also promoted the terminal differentiation of exhausted CD8 T cells by suppressing the effector-associated program. Together, the absence of TGF-β signaling resulted in significantly increased accumulation of effector-like CD8 T cells. These findings have implications for immunotherapies in general and especially for T cell therapy against chronic infections and cancer.

Indexed as

Lymphocytic ChoriomeningitisNeoplasmsAnimalsCD8-Positive T-LymphocytesLymphocytic choriomeningitis virusMicePersistent InfectionProgrammed Cell Death 1 ReceptorTransforming Growth Factor betaProgrammed Cell Death 1 ReceptorTransforming Growth Factor beta

Identifiers

PMID35980386
PMCPMC9393409
OpenAlexW4292202612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.